MARC Record from Library of Congress

LEADER: 02933cam a22004577a 4500
001 2012472834
003 DLC
005 20130515104936.0
008 130128s2011 dcua b 100 0 eng
010 $a 2012472834
016 7 $a101567107$2DNLM
016 7 $a015878001$2Uk
020 $a9780309163217 (pbk.)
020 $a0309163218 (pbk.)
035 $a(OCoLC)ocn705518868
040 $aNLM$beng$cNLM$dYDXCP$dNRZ$dEUW$dIUL$dUKMGB$dCDX$dDLC
042 $anlmcopyc$alccopycat
043 $an-us---
050 00 $aR857.N34$bN3583 2011
060 00 $a2011 I-118
060 10 $aQZ 200
082 00 $a362.196/9940072$223
245 00 $aNanotechnology and oncology :$bworkshop summary /$cMargie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
260 $aWashington,D.C. :$bNational Academies Press,$cc2011.
300 $axii, 106 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references (p. 69-71).
520 $a"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website.
530 $aAlso available online.
650 0 $aNanomedicine$vCongresses.
650 0 $aOncology$xResearch$zUnited States$vCongresses.
650 0 $aNanotechnology$vCongresses.
650 0 $aCancer$xTreatment$vCongresses.
650 12 $aNeoplasms$xtherapy$vCongresses.
650 22 $aNanomedicine$vCongresses.
650 22 $aNanotechnology$vCongresses.
700 1 $aPatlak, Margie.
700 1 $aMicheel, Christine.
710 2 $aInstitute of Medicine (U.S.).$bPlanning Committee on Policy Issues in Nanotechnology and Oncology.
710 2 $aNational Cancer Policy Forum (U.S.).
856 4 $uhttp://www.nap.edu/catalog.php?record%5Fid=13037
856 41 $uhttp://www.nap.edu/catalog.php?record_id=13037